No connection

Search Results

ONMD vs POM

ONMD
OneMedNet Corporation
BEARISH
Price
$0.88
Market Cap
$46.0M
Sector
Healthcare
AI Confidence
95%
POM
Pomdoctor Limited
BEARISH
Price
$0.38
Market Cap
$45.4M
Sector
Healthcare
AI Confidence
95%

Valuation

P/E Ratio
ONMD
--
POM
--
Forward P/E
ONMD
--
POM
--
P/B Ratio
ONMD
-15.47
POM
-0.04
P/S Ratio
ONMD
33.88
POM
0.12
EV/EBITDA
ONMD
-4.83
POM
-87.43

Profitability

Gross Margin
ONMD
-37.01%
POM
14.08%
Operating Margin
ONMD
-345.9%
POM
-6.54%
Profit Margin
ONMD
-206.11%
POM
-40.59%
ROE
ONMD
--
POM
--
ROA
ONMD
-205.58%
POM
-32.56%

Growth

Revenue Growth
ONMD
3326.9%
POM
16.2%
Earnings Growth
ONMD
--
POM
--

Financial Health

Debt/Equity
ONMD
--
POM
--
Current Ratio
ONMD
0.43
POM
0.17
Quick Ratio
ONMD
0.22
POM
0.09

Dividends

Dividend Yield
ONMD
--
POM
--
Payout Ratio
ONMD
0.0%
POM
0.0%

AI Verdict

ONMD BEARISH

The company exhibits critical financial distress, highlighted by a Piotroski F-Score of 0/9, indicating the weakest possible financial health. With a negative Price-to-Book ratio of -15.47 and a Current Ratio of 0.43, ONMD is facing a severe liquidity crisis and possesses negative shareholder equity. While the reported revenue growth of 3326.90% is astronomical, it is offset by a negative gross margin (-37.01%) and massive operating losses, suggesting that growth is currently being achieved at an unsustainable cost. The combination of bearish insider activity and a total lack of profitability makes this a high-risk speculative asset.

Strengths
Exceptional year-over-year revenue growth (3326.90%)
Operating within the high-demand Health Information Services industry
Recent short-term price recovery (+9.7% over 1 month)
Risks
Severe liquidity risk with a Current Ratio of 0.43
Negative gross margins indicate the core product is sold at a loss
Negative equity (P/B -15.47) suggests insolvency risk
POM BEARISH

Pomdoctor Limited exhibits severe financial distress, anchored by a weak Piotroski F-Score of 3/9 and a catastrophic liquidity profile. With a Current Ratio of 0.17 and a negative Price-to-Book ratio (-0.04), the company is effectively insolvent and unable to meet its short-term obligations. Despite a modest 16.2% revenue growth, the stock has collapsed by over 90% across all major timeframes, signaling a complete loss of investor confidence and high bankruptcy risk.

Strengths
Positive year-over-year revenue growth of 16.20%
Extremely low Price-to-Sales ratio (0.12)
Positive gross margin (14.08%)
Risks
Severe liquidity crisis with a Current Ratio of 0.17
Negative equity as indicated by the -0.04 Price/Book ratio
Massive price devaluation (-90.5% over 1 year)

Compare Another Pair

ONMD vs POM: Head-to-Head Comparison

This page compares OneMedNet Corporation (ONMD) and Pomdoctor Limited (POM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile